An hypothesis of initial conditions: Receptor-effector systems as determinants of psychopharmacologic drug response

International Journal of Neuropsychopharmacology

Volumn 1, Issue 2, 1998, Pages 137-151

  Rausch, Jeffrey L ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Alcohol; Antidepressants; Antipsychotics; Genetics; Initial conditions; Receptors; Temperament

Indexed keywords

EID: 0001044408     PISSN: 14611457     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1461145798001199     Document Type: Article

References (185)

1. Abraham WC, Tate WP (1997). Metaplasticity: a new vista across the field of synaptic plasticity. Progress in Neurobiology 52, 303-323.
2. Akaneya Y, Tsumoto T, Kinoshita S, Hatanaka H (1997). Brain-derived neurotrophic factor enhances long-term potentiation in rat visual cortex. Journal of Neuroscience 17, 6707-6716.
3. Aida M, Grof E, Cavazzoni P, Duffy A, Martin R, Ravindran L, Grof P (1997). Autosomal recessive inheritance of affective disorders in families of responders to lithium prophylaxis? Journal of Affective Disorders 44, 153-157.
4. Andreassen OA, MacEwan T, Gulbrandsen AK, McCreadie RG, Steen VM (1997). Non-functional CYP2D6 alleles and risk for neuroleptic-induced movement disorders in schizophrenic patients. Psychopharmacology (Berl) 131, 174-179.
5. Angst J (1964). Antidepressiver Effekt und Genetische Faktoren. Arzneim Forsch 14, 496-500.
6. Arias TD (1991). Uses and misuses of definitions of genetic polymorphism. A perspective from population pharmacogenetics. British Journal of Clinical Pharmacology 31, 117-119.
7. Arranz M, Collier D, Sodhi M, Ball D, Roberts G, Price J, Sham P, Kerwin R (1995). Association between clozapine response and allelic variation in 5-HT2A receptor gene. Lancet 346, 281-282.
8. Arranz MJ, Collier DA, Munro J, Sham P, Kirov G, Sodhi M, Roberts G, Price J, Kerwin RW (1996). Analysis of a structural polymorphism in the 5-HT2A receptor and clinical response to clozapine. Neuroscience Letters 217, 177-178.
9. Asghari V, Schoots O, van Kats S, Ohara K, Jovanovic V, Guan HC, Bunzow JR, Petronis A, Van Tol HH (1994). Dopamine D4 receptor repeat: analysis of different native and mutant forms of the human and rat genes. Molecular Pharmacology 46, 364-373.
10. Avissar S, Nechamkin Y, Barki-Harrington L, Roitman G, Schreiber G (1997). Differential G protein measures in mononuclear leukocytes of patients with bipolar mood disorder are state dependent. Journal of Affective Disorders 43, 85-93.
11. Bailey CH, Bartsch D, Kandel ER (1996). Toward a molecular definition of long-term memory storage. Proceedings of the National Academy of Sciences USA 93, 13445-1352.
12. Bailey CH, Kandel ER (1993). Structural changes accompanying memory storage. Annual Reviews in Physiology 55, 397-426.
13. Ball D, Hill L, Freeman B, Eley TC, Strelau J, Riemann R, Spinath FM, Angleitner A, Plomin R (1997). The serotonin transporter gene and peer-rated neuroticism. Neuroreport 8, 1301-1304.
14. Balon R (1989). Biological predictors of antidepressant treatment outcome. Clinical Neuropharmacology 12, 195-214.
15. Bardo MT, Donohew RL, Harrington NG (1996). Psychobiology of novelty-seeking and drug-seeking behavior. Behavioral Brain Research 77, 23-43.
16. Bartsch D, Ghirardi M, Skehel PA, Karl KA, Herder SP, Chen M, Bailey CH, Kandel ER (1995). Aplysia CREB2 represses long-term facilitation: relief of repression converts transient facilitation into long-term functional and structural change. Cell 83, 979-992.
17. Benjamin J, Li L, Patterson C, Greenberg BD, Murphy DL, Hamer DH (1996). Population and familial association between the D4 dopamine receptor gene and measures of Novelty-Seeking. Nature Genetics 12, 81-84.
18. Bertilsson L (1995). Geographical/interracial differences in polymorphic drug oxidation. Current state of knowledge of cytochromes P450 (CYP) 2D6 and 2C19. Clinical Pharmacokinetics 29, 192-209.
19. Bertilsson L, Dahl ML, Tybring G (1997). Pharmacogenetics of antidepressants: Clinical aspects. Acta Psychiatrica Scandinavica Supplement 391, 14-21.
20. Blenis J (1993). Signal transduction via the MAP kinases: proceed at your own RSK. Proceedings of the National Academy of Sciences USA 90, 5889-5892.
21. Bolshakov VY, Golan H, Kandel ER, Siegelbaum SA (1997). Recruitment of new sites of synaptic transmission during the cAMP-dependent late phase of LTP at CA3-CA1 synapses in the hippocampus. Neuron 19, 635-651.
22. Bonson KR, Buckholtz JW, Murphy DL (1996). Chronic administration of serotonergic antidepressants attenuates the subjective effects of LSD in humans. Neuropsychopharmacology 14, 425-436.
23. Bouchard TJ, Jr., Lykken DT, McGue M, Segal NL, Tellegen A (1990). Sources of human psychological differences: the Minnesota Study of Twins Reared Apart. Science 250, 223-228.
24. Chang FM, Kidd JR, Livak KJ, Pakstis AJ, Kidd KK (1996). The world-wide distribution of allele frequencies at the human dopamine D4 receptor locus. Human Genetics 98, 91-101.
25. Chang FM, Ko HC, Lu RB, Pakstis AJ, Kidd KK (1997). The dopamine D4 receptor gene (DRD4) is not associated with alcoholism in three Taiwanese populations: six polymorphisms tested separately and as haplotypes. Biological Psychiatry 41, 394-405.
26. Charlton ME, Sweetnam PM, Fitzgerald LW, Terwilliger RZ, Nestler EJ, Duman RS (1997). Chronic ethanol administration regulates the expression of GABAA receptor alpha 1 and alpha 5 subunits in the ventral tegmental area and hippocampus. Journal of Neurochemistry 68, 121-127.
27. Chen J, Rasenick MM (1995). Chronic antidepressant treatment facilitates G protein activation of adenylyl cyclase without altering G protein content. Journal of Pharmacology and Experimental Therapeutics 275, 509-517.
28. Cleland WW (1967). The statistical analysis of enzyme kinetic data. Advances in Enzymology 29, 1-32.
29. Cloninger CR (1994). Temperament and personality. Current Opinion in Neurobiology 4, 266-273.
30. Cohen J (1997). Developing prescriptions with a personal touch. Science 275 (5301), 776.
31. Cohen LJ, De Vane CL (1996). Clinical implications of antidepressant pharmacokinetics and pharmacogenetics. Annals of Pharmacotherapy 30, 1471-1480.
32. Colin SF, Chang HC, Mollner S, Pfeuffer T, Reed RR, Duman RS, Nestler EJ (1991). Chronic lithium regulates the expression of adenylate cyclase and Gi-protein alpha subunit in rat cerebral cortex. Proceedings of the National Academy of Sciences USA 88, 10634-10637.
33. Collier DA, Stober G, Li T, Heils A, Catalano M, Di Bella D, Arranz MJ, Murray RM, Vallada HP, Bengel D, Muller CR, Roberts GW, Smeraldi E, Kirov G, Sham P, Lesch KP (1996). A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Molecular Psychiatry 1, 453-460.
34. Compton PA, Anglin MD, Khalsa-Denison ME, Paredes A (1996). The D2 dopamine receptor gene, addiction, and personality: clinical correlates in cocaine abusers. Biological Psychiatry 39, 302-304.
35. Cook CC, Palsson G, Turner A, Holmes D, Brett P, Curtis D, Petursson H, Gurling HM (1996). A genetic linkage study of the D2 dopamine receptor locus in heavy drinking and alcoholism. British Journal of Psychiatry 169, 243-248.
36. Cruz C, Camarena B, King N, Paez F, Sidenberg D, de la Fuente JR, Nicolini H (1997). Increased prevalence of the seven-repeat variant of the dopamine D4 receptor gene in patients with obsessive-compulsive disorder with tics. Neuroscience Letters 231, 1-4.
37. Dash PK, Moore AN (1996). Characterization and phosphorylation of CREB-like proteins in Aplysia central nervous system. Brain Research and Molecular Brain Research 39, 43-51.
38. Deisseroth K, Bito H, Tsien RW (1996). Signaling from synapse to nucleus: postsynaptic CREB phosphorylation during multiple forms of hippocampal synaptic plasticity. Neuron 16, 89-101.
39. DeRosa C, Richter P, Pohl H, Jones DE (1998). Environmental exposures that affect the endocrine system: public health implications. Journal of Toxicology and Environmental Health B: Critical Reviews 1, 3-26.
40. Deutsch SI, Rosse RB, Mastropaolo J (1994). Environmental stress-induced functional modification of the central benzodiazepine binding site. Clinical Neuropharmacology 17, 205-228.
41. Dinan TG (1996). Noradrenergic and serotonergic abnormalities in depression: stress-induced dysfunction? Journal of Clinical Psychiatry 57, Supplement 4: 14-18.
42. Dobashi I, Inada T, Hadano K (1997). Alcoholism and gene polymorphisms related to central dopaminergic transmission in the Japanese population. Psychiatric Genetics 7, 87-91.
43. Dragunow M (1996). A role for immediate-early transcription factors in learning and memory. Behavioral Genetics 26, 293-299.
44. Dragunow M, Hughes P, Mason-Parker SE, Lawlor P, Abraham WC (1997). TrkB expression in dentate granule cells is associated with a late phase of long-term potentiation. Brain Research and Molecular Brain Research 46, 274-280.
45. Duman RS, Heninger GR, Nestler EJ (1997). A molecular and cellular theory of depression (see comments). Archives of General Psychiatry 54, 597-606.
46. Ebstein RP, Gritsenko I, Levine J, Geller V, Auerbach J, Belmaker RH (1998) Dopamine D4 receptor and serotonin transporter promoter in the determination of neonatal temperament. International Journal of Neuropsychopharmacology 1 (Supplement 1) S9.
47. Ebstein RP, Gritsenko I, Nemanov L, Frisch A, Osher Y, Belmaker RH (1997). No association between the serotonin transporter gene regulatory region polymorphism and the Tridimensional Personality Questionnaire (TPQ) temperament of harm avoidance. Molecular Psychiatry 2, 224-226.
48. Ebstein RP, Novick O, Umansky R, Priel B, Osher Y, Blaine D, Bennett ER, Nemanov L, Katz M, Belmaker RH (1996). Dopamine D4 receptor (D4DR) exon III polymorphism associated with the human personality trait of Novelty-Seeking. Nature Genetics 12, 78-80.
49. Ebstein RP, Nemanov L, Klotz I, Gritsenko I, Belmaker RH (1997). Additional evidence for an association between the dopamine D4 receptor (D4DR) exon III repeat polymorphism and the human personality trait of Novelty-Seeking. Molecular Psychiatry 2, 472-477.
50. Ebstein RP, Segman R, Benjamin J, Osher Y, Nemanov L, Belmaker RH (1997). 5-HT2C (HTR2C) serotonin receptor gene polymorphism associated with the human personality trait of reward dependence: interaction with dopamine D4 receptor (D4DR) and dopamine D3 receptor (D3DR) polymorphisms. American Journal of Medical Genetics 74, 65-72.
51. Emouf D, Compagnon P, Lothion P, Narcisse G, Benard JY, Daoust M (1993). Platelets 3H 5-HT uptake in descendants from alcoholic patients: a potential risk factor for alcohol dependence? Life Sciences 52, 989-995.
52. Espinos C, Sanchez F, Ramirez C, Juan F, Najera C (1997). Polymorphism of alcohol dehydrogenase genes in alcoholic and nonalcoholic individuals from Valencia (Spain). Hereditas 126, 247-253.
53. Fagnou DD, Tuchek JM (1995). The biochemistry of learning and memory. Molecular and Cell Biochemistry 149-150, 279-286.
54. Falk CT, Rubinstein P (1987). Haplotype relative risks: an easy reliable way to construct a proper control sample for risk calculations. Annals of Human Genetics 51, 227-233.
55. Faraj BA, Olkowski ZL, Jackson RT (1997). Prevalence of high serotonin uptake in lymphocytes of abstinent alcoholics. Biochemical Pharmacology 53(1), 53-57.
56. Floderus-Myrhed B, Pedersen N, Rasmuson I (1980). Assessment of heritability for personality, based on a short-form of the Eysenck Personality Inventory: a study of 12,898 twin pairs. Behavioral Genetics 10, 153-162.
57. Fujikawa T, Yoshizato H, Soya H, Nakashima K (1996). Dynamic alterations in growth hormone receptor RNA levels in rat brain during stress tolerance. Endocrine Journal 43 (Supplement), S119-S122.
58. Garcia-Sevilla JA, Walzer C, Busquets X, Escriba PV, Balant L, Guimon J (1997). Density of guanine nucleotide-binding proteins in platelets of patients with major depression: increased abundance of the G alpha i2 subunit and downregulation by antidepressant drug treatment. Biological Psychiatry 42, 704-712.
59. Gelernter J, Kranzler H, Coccaro E, Siever L, New A, Mulgrew CL (1997). D4 dopamine-receptor (DRD4) alleles and novelty seeking in substance-dependent, personality-disorder, and control subjects. American Journal of Human Genetics 61, 1144-1152.
60. Gelernter J, Kranzler HR, Satel SL, Rao PA (1994). Genetic association between dopamine transporter protein alleles and cocaine-induced paranoia. Neuropsychopharmacology 11, 195-200.
61. Ghi P, Blengio M, Ferretti C, Portaleone P (1995). Stress and brain H3-histamine receptors. Inflammation Research 44 (Supplement 1), S62-S63.
62. Goldman D (1995a). World congress on psychiatric genetics. Psychiatric Genetics 5 (Supplement 1), S22.
63. Goldman D (1995b). Candidate genes in alcoholism. Clinical Neurosciece 3, 174-181.
64. Goldman D (1996). High anxiety. Science 274, 1527-1531.
65. Harada S (1997). Genetic association between aldehyde dehydrogenase alleles and alcoholism. Nippon Rinsho 55 (Supplement), 346-350.
66. Hartman DS, Lanau F (1997). Diversity of dopamine receptors: new molecular and pharmacological developments. Polish Journal of Pharmacology 49, 191-199.
67. Heils A, Mossner R, Lesch KP (1997). The human serotonin transporter gene polymorphism - basic research and clinical implications. Journal of Neural Transmission 104, 1005-1014.
68. Heinz A, Sander T, Harms H, Finckh U, Kuhn S, Dufeu P, Dettling M, Graf K, Rolfs A, Rommelspacher H, Schmidt LG (1996). Lack of allelic association of dopamine D1 and D2 (TaqIA) receptor gene polymorphisms with reduced dopaminergic sensitivity to alcoholism. Alcoholism: Clinical and Experimental Research 20, 1109-1113.
69. Hietala J, Pohjalainen T, Heikkila-Kallio U, West C, Salaspuro M, Syvalahti E (1997). Allelic association between D2 but not D1 dopamine receptor gene and alcoholism in Finland. Psychiatric Genetics 7, 19-25.
70. Hong CJ, Lee YL, Sim CB, Hwu HG (1997). Dopamine D4 receptor variants in Chinese sporadic and familial schizophrenics. American Journal of Medical Genetics 74, 412-415.
71. Huether G, Zhou D, Ruther E (1997). Long-term modulation of presynaptic 5-HT-output: experimentally-induced changes in cortical 5-HT-transporter density, tryptophan hydroxylase content and 5-HT innervation density. Journal of Neural Transmission 104, 993-1004.
72. Hyman SE, Nestler EJ (1996). Initiation and adaptation: a paradigm for understanding psychotropic drug action. American Journal of Psychiatry 153, 151-162.
73. Jang KL, Livesley WJ, Vernon PA (1996). Heritability of the big five personality dimensions and their facets: a twin study. Journal of Personality 64, 577-591.
74. Jeste DV, Kelsoe JR (1997). Schizophrenia, tardive dyskinesia, and a D3 receptor gene variant: a new twist on dyskinesia? Molecular Psychiatry 2, 86-88.
75. Jonsson EG, Nöthen MM, Gustavsson JP, Neidt H, Brene S, Tylec A, Propping P, Sedvall GC (1997). Lack of evidence for allelic association between personality traits and the dopamine D4 receptor gene polymorphisms. American Journal of Psychiatry 15, 697-699.
76. Joyce PR, Mulder RT, Cloninger CR (1994). Temperament predicts clomipramine and desipramine response in major depression [see comments]. Journal of Affective Disorders 30, 35-46.
77. Kang H, Schuman EM (1995). Long-lasting neurotrophin-induced enhancement of synaptic transmission in the adult hippocampus. Science 267, 1658-1662.
78. Kerwin RW, Pilowsky L, Munro J, Shaikh S, Gill M, Collier D (1994). Functional neuroimaging and pharmacogenetic studies of clozapine's action at dopamine receptors. Journal of Clinical Psychiatry 55 (Supplement B), 57-62.
79. Kidd KK, Pakstis AJ, Castiglione CM, Kidd JR, Speed WC, Goldman D, Knowler WC, Lu RB, Bonne-Tamir B (1996). DRD2 haplotypes containing the TaqI A1 allele: implications for alcoholism research. Alcoholism: Clinical and Experimental Research 20, 697-705.
80. Kohn Y, Ebstein RP, Heresco-Levy U, Shapira B, Nemanov L, Gritsenko I, Avnon M, Lerer B (1997). Dopamine D4 receptor gene polymorphisms: relation to ethnicity, no association with schizophrenia and response to clozapine in Israeli subjects. European Neuropsychopharmacology 7, 39-43.
81. Korte M, Bonhoeffer T (1997). Activity-dependent synaptic plasticity: a new face of action for neurotrophins (News). Molecular Psychiatry 2, 197-199.
82. Korte M, Griesbeck O, Gravel C, Carroll P, Staiger V, Thoenen H, Bonhoeffer T (1996). Virus-mediated gene transfer into hippocampal CA1 region restores long-term potentiation in brain-derived neurotrophic factor mutant mice. Proceedings of the National Academy of Sciences USA 93, 12547-12552.
83. Korte M, Staiger V, Griesbeck O, Thoenen H, Bonhoeffer T (1996). The involvement of brain-derived neurotrophic factor in hippocampal long-term potentiation revealed by gene targeting experiments. Journal of Physiology of Paris 90, 157-164.
84. Kotler M, Cohen H, Segman R, Gritsenko I, Nemanov L, Lerer B, Kramer I, Zer-Zion M, Kletz I, Ebstein RP (1997). Excess dopamine D4 receptor (D4DR) exon III seven repeat allele in opioid-dependent subjects. Molecular Psychiatry 2, 251-254.
85. Kunugi H, Hattori M, Kato T, Tatsumi M, Sakai T, Sasaki T, Hirose T, Nanko S (1997). Serotonin transporter gene polymorphisms: ethnic difference and possible association with bipolar affective disorder. Molecular Psychiatry 2, 457-462.
86. Kupfer DJ (1993). Management of recurrent depression. Journal of Clinical Psychiatry 54 Supplement, 29-33 (Discussion).
87. Kuribara H (1997). Induction of sensitization to hyperactivity caused by morphine in mice: effects of post-drug environments. Pharmacology, Biochemistry and Behavior 57, 341-346.
88. Lader MH (1996). Tolerability and safety: essentials in antidepressant pharmacotherapy. Journal of Clinical Psychiatry 57 (Supplement 2), 39-44.
89. LaHoste GJ, Swanson JM, Wigal SB, Glabe C, Wigal T, King N, Kennedy JL (1996). Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder [see comments]. Molecular Psychiatry 1, 121-124.
90. Lappalainen J, Zhang L, Dean M, Oz M, Ozaki N, Yu DH, Virkkunen M, Weight F, Linnoila M, Goldman D (1995). Identification, expression, and pharmacology of a Cys23-Ser23 substitution in the human 5-HT2c receptor gene (HTR2C). Genomics 27, 274-279.
91. Lawford BR, Young RM, Rowell JA, Gibson JN, Feeney GF, Ritchie TL, Syndulko K, Noble EP (1997). Association of the D2 dopamine receptor A1 allele with alcoholism: medical severity of alcoholism and type of controls. Biological Psychiatry 41, 386-393.
92. Lee MS, Lee KJ, Kwak DI (1997). No association between the dopamine D2 receptor gene and Korean alcoholism. Psychiatric Genetics 7, 93-95.
93. Lehrman S (1997). Slick new company eyes medical diagnostics market. Nature 389 (6647), 107.
94. Lerman C, Caporaso N, Main D, Audrain J, Boyd NR, Bowman ED, Shields PG (1996). Depression and self-medication with nicotine: the modifying influence of the dopamine D4 receptor gene. Health Psychology 17, 56-62.
95. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, Benjamin J, Muller CR, Hamer DH, Murphy DL (1996). Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science (5292), 1527-1531.
96. Lesch KP, Gross J, Franzek E, Wolozin BL, Riederer P, Murphy DL (1995). Primary structure of the serotonin transporter in unipolar depression and bipolar disorder. Biological Psychiatry 37, 215-223.
97. Levine ES, Black IB, Plummer MR (1998). Neurotrophin modulation of hippocampal synaptic transmission. Advances in Pharmacology 42, 921-924.
98. Levine ES, Dreyfus CF, Black IB, Plummer MR (1995). Brain-derived neurotrophic factor rapidly enhances synaptic transmission in hippocampal neurons via postsynaptic tyrosine kinase receptors. Proceedings of the National Academy of Sciences USA 92, 8074-8077.
99. Li T, Xu K, Deng H, Cai G, Liu J, Liu X, Wang R, Xiang X, Zhao J, Murray RM, Sham PC, Collier DA (1997). Association analysis of the dopamine D4 gene exon III VNTR and heroin abuse in Chinese subjects. Molecular Psychiatry 2, 413-416.
100. Lichter JB, Barr CL, Kennedy JL, Van Tol HH, Kidd KK, Livak KJ (1993). A hypervariable segment in the human dopamine receptor D4 (DRD4) gene. Human Molecular Genetics, 767-773.
101. Linnarsson S, Bjorklund A, Ernfors P (1997). Learning deficit in BDNF mutant mice. European Journal of Neuroscience 9, 2581-2587.
102. Little KY, McLaughlin DP, Zhang L, Livermore CS, Dalack GW, McFinton PR, DelProposto ZS, Hill E, Cassin BJ, Watson SJ, Cook EH (1998). Cocaine, ethanol, and genotype effects on human midbrain serotonin transporter binding sites and mRNA levels. American Journal of Psychiatry 155, 207-213.
103. Liu IS, Seeman P, Sanyal S, Ulpian C, Rodgers-Johnson PE, Serjeant GR, Van Tol HH (1996). Dopamine D4 receptor variant in Africans, D4valine194glycine, is insensitive to dopamine and clozapine: report of a homozygous individual. American Journal of Medical Genetics 61, 277-282.
104. Livak KJ, Rogers J, Lichter JB (1995). Variability of dopamine D4 receptor (DRD4) gene sequence within and among nonhuman primate species. Proceedings of National Academy of Sciences USA 92, 427-431.
105. Ma YL, Wang HL, Wu HC, Wei CL, Lee EH (1998). Brain-derived neurotrophic factor antisense oligonucleotide impairs memory retention and inhibits long-term potentiation in rats. Neuroscience 82, 957-967.
106. Macaskill GT, Hopper JL, White V, Hill DJ (1994). Genetic and environmental variation in Eysenck Personality Questionnaire scales measured on Australian adolescent twins. Behavioral Genetics 24, 481-491.
107. Maezawa Y, Yamauchi M, Searashi Y, Takeda K, Mizuhara Y, Kimura T, Toda G, Suzuki H, Sakurai S (1996). Association of restriction fragment-length polymorphisms in the alcohol dehydrogenase 2 gene with alcoholic brain atrophy. Alcoholism: Clinical and Experimental Research 20, 29A-32A.
108. Magos AL, Brewster E, Singh R, O'Dowd T, Brincat M, Studd JW (1986). The effects of norethisterone in postmenopausal women on oestrogen replacement therapy: a model for the premenstrual syndrome. British Journal of Obstetrics and Gynaecology 93, 1290-1296.
109. Malhotra AK, Goldman D, Buchanan RW, Rooney W, Clifton A, Kosmidis MH, Breier A, Pickar D (1998). The dopamine D3 receptor (DRD3) Ser9Gly polymorphism and schizophrenia: a haplotype relative risk study and association with clozapine response. Molecular Psychiatry 3, 72-75.
110. Malhotra AK, Goldman D, Ozaki N, Breier A, Buchanan R, Pickar D (1996a). Lack of association between polymorphisms in the 5-HT2A receptor gene and the antipsychotic response to clozapine. American Journal of Psychiatry 153, 1092-1094.
111. Malhotra AK, Goldman D, Ozaki N, Rooney W, Clifton A, Buchanan RW, Breier A, Pickar D (1996b). Clozapine response and the 5HT2C Cys23Ser polymorphism. Neuroreport 7, 2100-2102.
112. Malhotra AK, Virkkunen M, Rooney W, Eggert M, Linnoila M, Goldman D (1996c). The association between the dopamine D4 receptor (D4DR) 16 amino acid repeat polymorphism and novelty-seeking. Molecular Psychiatry 1, 388-391.
113. Martin KC, Casadio A, Zhu H, E Y, Rose JC, Chen M, Bailey CH, Kandel ER (1997). Synapse-specific, long-term facilitation of aplysia sensory to motor synapses: a function for local protein synthesis in memory storage. Cell 91, 927-938.
114. Masimirembwa CM, Hasler JA (1997). Genetic polymorphism of drug metabolising enzymes in African populations: implications for the use of neuroleptics and antidepressants. Brain Research Bulletin 4, 561-571.
115. Matsumoto M, Takahashi H, Maruyama K, Higuchi S, Matsushita S, Muramatsu T, Okuyama K, Yokoyama A, Nakano M, Ishii H (1996). Genotypes of alcohol-metabolizing enzymes and the risk for alcoholic chronic pancreatitis in Japanese alcoholics. Alcoholism: Clinical and Experimental Research 20, 289-292.
116. McCormick CM, Smythe JW, Sharma S, Meaney MJ (1995). Sex-specific effects of prenatal stress on hypothalamic-pituitary-adrenal responses to stress and brain glucocorticoid receptor density in adult rats. Brain Research and Developmental Brain Research 84, 55-61.
117. Menkes DB, Rasenick MM, Wheeler MA, Bitensky MW (1983). Guanosine triphosphate activation of brain adenylate cyclase: enhancement by long-term antidepressant treatment. Science 219, 65-67.
118. Meyer UA, Amrein R, Balant LP, Bertilsson L, Eichelbaum M, Guentert TW, Henauer S, Jackson P, Laux G, Mikkelsen H, Peck C, Pollock BG, Priest R, Sjoqvist F, Delini-Stula A (1996). Antidepressants and drug-metabolizing enzymes-expert group report. Acta Psychiatrica Scandinavica 93, 71-79.
119. Morinobu S, Strausbaugh H, Terwilliger R, Duman RS (1997). Regulation of c-Fos and NGF1-A by antidepressant treatments. Synapse 25, 313-320.
120. Muramatsu T, Higuchi S, Murayama M, Matsushita S, Hayashida M (1996). Association between alcoholism and the dopamine D4 receptor gene. Journal of Medical Genetics 33, 113-115.
121. Nakamura T, Muramatsu T, Ono Y, Matsushita S, Higuchi S, Mizushima H, Yoshimura K, Kanba S, Asai M (1997). Serotonin transporter gene regulatory region polymorphism and anxiety-related traits in the Japanese. American Journal of Medical Genetics 74, 544-545.
122. Nelson E, Cloninger CR (1997). Exploring the TPQ as a possible predictor of antidepressant response to nefazodone in a large multi-site study. Journal of Affective Disorders 44, 197-200.
123. Nestler EJ, Terwilliger RZ, Duman RS (1989). Chronic antidepressant administration alters the subcellular distribution of cyclic AMP-dependent protein kinase in rat frontal cortex. Journal of Neurochemislry 53, 1644-1647.
124. Nguyen PV, Kandel ER (1996). A macromolecular synthesis-dependent late phase of long-term potentiation requiring cAMP in the medial perforant pathway of rat hippocampal slices. Journal of Neuroscience 1, 3189-3198.
125. Nöthen MM, Cichon S, Hemmer S, Hebebrand J, Remschmidt H, Lehmkuhl G, Poustka F, Schmidt M, Catalano M, Fimmers R, et al. (1994). Human dopamine D4 receptor gene: frequent occurrence of a null allele and observation of homozygosity. Human Molecular Genetics 3, 2207-2212.
126. Ogilvie AD, Battersby S, Bubb VJ, Fink G, Harmar AJ, Goodwim GM, Smith CA (1996). Polymorphism in serotonin transporter gene associated with susceptibility to major depression (see comments). Lancet 347, 731-733.
127. Ono Y, Manki H, Yoshimura K, Muramatsu T, Mizushima H, Higuchi S, Yagi G, Kanba S, Asai M (1997). Association between dopamine D4 receptor (D4DR) exon III polymorphism and novelty-seeking in Japanese subjects. American Journal of Medical Genetics 74, 501-503.
128. O'Reilly RL, Bogue L, Singh SM (1994). Pharmacogenetic response to antidepressants in a multicase family with affective disorder. Biological Psychiatry 36, 467-471.
129. Overstreet DH, Karan L, Rosecrans JA (1995). Genetic, environmental, and situational factors mediating the effects of nicotine - an introduction. Behavioral Genetics 25, 93-94.
130. Ozaki N, Manji H, Lubierman V, Lu SJ, Lappalainen J, Rosenthal NE, Goldman D (1997). A naturally occurring amino acid substitution of the human serotonin 5-HT2A receptor influences amplitude and timing of intracellular calcium mobilization. Journal of Neurochemistry 68, 2186-2193.
131. Ozawa H, Katamura Y, Hatta S, Amemiya N, Saito T, Ohshika H, Takahata N (1994). Antidepressants directly influence in situ binding of guanine nucleotide in synaptic membrane. Life Sciences 54, 925-932.
132. Ozawa H, Rasenick MM (1991). Chronic electroconvulsive treatment augments coupling of the GTP-binding protein Gs to the catalytic moiety of adenylyl cyclase in a manner similar to that seen with chronic antidepressant drugs. Journal of Neurochemistry 5, 330-338.
133. Pare CMB, Mack JW (1971). Differentiation of two genetically specific types of depression by the response to antidepressant drugs. Journal of Medical Genetics 8, 306-309.
134. Pare CMB, Rees L, Sainsbury MJ (1962). Differentiation of two genetically specific types of depression by the response to antidepressant treatment. Lancet II, 1340-1343.
135. Parsian A, Chakraverty S, Fisher L, Cloninger CR (1997). No association between polymorphisms in the human dopamine D3 and D4 receptors genes and alcoholism. American Journal of Medical Genetics 74, 281-285.
136. Parsian A, Cloninger CR (1997). Human GABAA receptor alpha 1 and alpha 3 subunits genes and alcoholism. Alcoholism: Clinical and Experimental Research 21, 430-433.
137. Pedersen NL, Plomin R, McClearn GE, Friberg L (1988). Neuroticism, extraversion, and related traits in adult twins reared apart and reared together. Journal of Personality and Social Psychology 55, 950-957.
138. Peng CK, Buldyrev SV, Hausdorff JM, Havlin S, Mietus JE, Simons M, Stanley HE, Goldberger AL (1994). Non-equilibrium dynamics as an indispensable characteristic of a healthy biological system. Integrative Physiological and Behavioral Science 29, 283-293.
139. Perez J, Tinelli D, Brunello N, Racagni G (1989). cAMP-dependent phosphorylation of soluble and crude microtubule fractions of rat cerebral cortex after prolonged desmethylimipramine treatment. European Journal of Pharmacology 172, 305-316.
140. Perez de Castro I, Ibanez A, Torres P, Saiz-Ruiz J, Fernandez-Piqueras J (1997). Genetic association study between pathological gambling and a functional DNA polymorphism at the D4 receptor gene. Pharmacogenetics 7, 345-348.
141. Persico AM, Bird G, Gabbay FH, Uhl GR (1996). D2 dopamine receptor gene TaqI A1 and B1 restriction fragment length polymorphisms: enhanced frequencies in psychostimulant-preferring polysubstance abusers. Biological Psychiatry 40, 776-784.
142. Phillips TJ (1997). Behavior genetics of drug sensitization. Critical Reviews in Neurobiology 11, 21-33.
143. Plomin R, Emde RN, Braungart JM, Campos J, Corley R, Fulker DW, Kagan J, Reznick JS, Robinson J, Zahn-Waxler C, et al. (1993). Genetic change and continuity from fourteen to twenty months: the MacArthur Longitudinal Twin Study. Child Development 64, 1354-1376.
144. Poincaré Henri (1899). Les Méthodes Nouvelles de la Mécanique Céleste [New Methods of Celestial Mechanics (History of Modern Physics and Astronomy] Vol 13. American Institute of Physics.
145. Pokk P, Kivastik T, Sobol D, Liljequist S, Zharkovsky A (1996). Is upregulation of benzodiazepine receptors a compensatory reaction to reduced GABAergic tone in the brain of stressed mice? Naunyn Schmiedebergs Archives Pharmacologie 354, 703-708.
146. Pomerleau OF (1995). Individual differences in sensitivity to nicotine: implications for genetic research on nicotine dependence. Behavioral Genetics 25, 161-177.
147. Propping P, Friedl W (1979). Genetic influences on pharmacodynamic properties of psychotropic drugs. Pharmacology 19, 1-4.
148. Propping P, Nöthen MM (1995). Genetic variation in CNS receptors - a new perspective for pharmacogenetics. Pharmacogenetics 5, 318-325.
149. Rao PA, Pickar D, Gejman PV, Ram A, Gershon ES, Gelernter J (1994). Allelic variation in the D4 dopamine receptor (DRD4) gene does not predict response to clozapine. Archives of General Psychiatry 51, 912-917.
150. Rasenick MM, Chaney KA, Chen J (1996). G protein-mediated signal transduction as a target of antidepressant and antibipolar drug action: evidence from model systems. Journal of Clinical Psychiatry 57 (Supplement 13), 49-55.
151. Rausch JL, Fei Y, Ganapathy V, Leibach F (1995). Restriction fragment length polymorphisms in gene 5-HTT sequence. Biological Psychiatry 37, 623.
152. Rausch JL, Fei Y, Li J, Ganapathy V, Leibach FH (1997). Linkage disequilibrium between sert vntr and promoter region base pair deletion: Relevance to alcoholism risk. World Congress on Psychiatric Genetics.
153. Rausch JL, Hobby HM, Shendarkar N, Li J (1997). Fluvoxamine treatment of mixed anxiety and depression: Evidence for serotonergically mediated anxiolysis. CINP Regional Meeting
154. Rausch JL, Moeller FG, Stahl SM (1993). Prediction of early nortriptyline response. American Psychiatric Association Scientific Proceedings 146, 98.
155. Rausch JL, Monteiro MG, Schuckit MA (1991). Platelet serotonin uptake in men with family histories of alcoholism. Neuropsychopharmacology 4, 83-86.
156. Rietschel M, Naber D, Fimmers R, Moller HJ, Propping P, Nöthen MM (1997). Efficacy and side-effects of clozapine not associated with variation in the 5-HT2C receptor. Neuroreport 8, 1999-2003.
157. Rietschel M, Naber D, Oberlander H, Holzbach R, Fimmers R, Eggermann K,
158. Rose RJ (1988). Genetic and environmental variance in content dimensions of the MMPI. Journal of Personality and Social Psychology 55, 302-311.
159. Sander T, Harms H, Dufeu P, Kuhn S, Rommelspacher H, Schmidt LG (1997). Dopamine D4 receptor exon III alleles and variation of novelty-seeking in alcoholics. American Journal of Medical Genetics 74, 483-487.
160. Sander T, Harms H, Lesch KP, Dufeu P, Kuhn S, Hoehe M, Rommelspacher H, Schmidt LG (1997). Association analysis of a regulatory variation of the serotonin transporter gene with severe alcohol dependence. Alcoholism: Clinical and Experimental Research 21, 1356-1359.
161. Sander T, Harms H, Podschus J, Finckh U, Nickel B, Rolfs A, Rommelspacher H, Schmidt LG (1995). Dopamine D1, D2 and D3 receptor genes in alcohol dependence. Psychiatric Genetics 5, 171-176.
162. Sander T, Harms H, Podschus J, Finckh U, Nickel B, Rolfs A, Rommelspacher H, Schmidt LG (1997). Allelic association of a dopamine transporter gene polymorphism in alcohol dependence with withdrawal seizures or delirium. Biological Psychiatry 47, 299-304.
163. Senba E, Ueyama T (1997). Stress-induced expression of immediate early genes in the brain and peripheral organs of the rat. Neuroscience Research 29, 183-207.
164. Shaikh S, Collier DA, Sham P, Pilowsky L, Sharma T, Lin LK, Crocq MA, Gill M, Kerwin R (1995). Analysis of clozapine response and polymorphisms of the dopamine D4 receptor gene (DRD4) in schizophrenic patients. American Journal of Medical Genetics 60, 541-545.
165. Shaikh S, Collier DA, Sham PC, Ball D, Aitchison K, Vailada H, Smith I, Gill M, Kerwin RW (1996). Allelic association between a Ser-9-Gly polymorphism in the dopamine D3 receptor gene and schizophrenia. Human Genetics 97, 714-719.
166. Shen L, Figurov A, Lu B (1997). Recent progress in studies of neurotrophic factors and their clinical implications. Journal of Molecular Medicine 75, 637-644.
167. Slotkin TA, Barnes GA, McCook EC, Seidler FJ (1996). Programming of brainstem serotonin transporter development by prenatal glucocorticoids. Brain Research and Developmental Brain Research 93, 155-161.
168. Sodhi MS, Arranz MJ, Curtis D, Ball DM, Sham P, Roberts GW, Price J, Collier DA, Kerwin RW (1995). Association between clozapine response and allelic variation in the 5-HT2C receptor gene. Neuroreport 7, 169-172.
169. Steen VM, Lovlie R, MacEwan T, McCreadie RG (1997). Dopamine D3-receptor gene variant and susceptibility to tardive dyskinesia in schizophrenic patients. Molecular Psychiatry 2, 139-145.
170. Stoop R, Poo MM (1996). Synaptic modulation by neurotrophic factors. Progress in Brain Research 109, 359-364.
171. Sullivan PF, Fifield WJ, Kennedy MA, Mulder RT, Sellman JD, Joyce PR (1998). No association between novelty-seeking and the type 4 dopamine receptor gene (DRD4) in two New Zealand samples. American Journal of Psychiatry 155, 98-101.
172. Swanson JM, Sunohara GA, Kennedy JL, Regino R, Fineberg E, Wigal T, Lerner M, Williams L, LaHoste GJ, Wigal S (1998). Association of the dopamine receptor D4 (DRD4) gene with a refined phenotype of attention deficit hyperactivity disorder (ADHD): a family-based approach. Molecular Psychiatry 3, 38-41.
173. Takeshita T, Mao XQ, Morimoto K (1996). The contribution of polymorphism in the alcohol dehydrogenase beta subunit to alcohol sensitivity in a Japanese population. Human Genetics 97, 409-413.
174. Tanaka F, Shiratori Y, Yokosuka O, Imazeki F, Tsukada Y, Omata M (1997). Polymorphism of alcohol-metabolizing genes affects drinking behavior and alcoholic liver disease in Japanese men. Alcoholism: Clinical and Experimental Research 21, 596-601.
175. Tome MB, Cloninger CR, Watson JP, Isaac MT (1997). Serotonergic autoreceptor blockade in the reduction of antidepressant latency: personality variables and response to paroxetine and pindolol. Journal of Affective Disorders 44, 101-109.
176. Tsai G, Coyle JT (1998). The role of glutamatergic neurotransmission in the pathophysiology of alcoholism. Annual Reviews in Medicine 49, 173-184.
177. Uhl GR, Vandenbergh DJ, Rodriguez LA, Miner L, Takahashi N (1998). Dopaminergic genes and substance abuse. Advances in Pharmacology 42, 1024-1032.
178. Van Tol HH, Wu CM, Guan HC, Ohara K, Bunzow JR, Civelli O, Kennedy J, Seeman P, Niznik HB, Jovanovic V (1992). Multiple dopamine D4 receptor variants in the human population. Nature 358, 149-152.
179. Vandenbergh DJ, Zonderman AB, Wang J, Uhl GR, Costa PT, Jr. (1997). No association between novelty-seeking and dopamine D4 receptor (D4DR) exon III seven repeat alleles in Baltimore Longitudinal Study of Aging participants. Molecular Psychiatry 2, 417-419.
180. Vathy I (1995). Effects of prenatal morphine and cocaine on postnatal behaviors and brain neurotransmitters. NIDA Research Monographs 158, 88-114.
181. Vogel F (1987). Research strategies in human behaviour genetics. Journal of Medical Genetics 24, 129-138.
182. Wells KB, Stewart A, Hays RD, Bumam MA, Rogers W, Daniels M, Berry S, Greenfield S, Ware J (1989). The functioning and well-being of depressed patients. Results from the Medical Outcomes Study. Journal of the Amercian Medical Association 262, 914-919.
183. Widnell KL, Russell DS, Nestler EJ (1994). Regulation of expression of cAMP response element-binding protein in the locus coeruleus in vivo and in a locus coeruleus-like cell line in vitro. Proceedings of the National Academy of Science USA 91, 10947-10951.
184. Young LT, Li PP, Kamble A, Siu KP, Warsh JJ (1996). Lack of effect of antidepressants on mononuclear leukocyte G-protein levels or function in depressed outpatients. Journal of Affective Disorders 39, 201-207.
185. Zimmerberg B, Smith CD, Weider JM, Teitler M (1995). The development of B1-adrenoceptors in brown adipose tissue after prenatal alcohol exposure. Alcohol 12, 71-77.